Epival CR 300 mg prolonged-release tablets

Manufacturer/MA Holder: Gerot Lannach UK Ltd/G.L. Pharma GmbH
MA Number: PL 21597/0005

Important information

Please refer to the MHRA PREVENT Programme.

Drug Safety Category

2

Active Ingredient

Valproate (Sodium Valporate, Valproic Acid, Valproate Semisodium)

Formulation

Prolonged Release Tablet

Strength

300mg

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

No

Length/Diameter

Unknown

SPC URL

Open SPC

Excipients of concern

Sodium Content42mg